Abstract:ABSTRACT With its estrogenic activity, ( S )-equol plays an important role in maintaining host health and preventing estrogen-related diseases. Exclusive production occurs through the transformation of soy isoflavones by intestinal bacteria, but the reasons for variations in ( S )-equol production among different individuals and species remain unclear. Here, fecal samples from humans, pigs, chickens, mice, and rats were used as research objects. The concentrations of ( S )-equol, along with the genetic homology and evolutionary relationships of ( S )-equol production-related genes [daidzein reductase (DZNR), daidzein racemase (DDRC), dihydrodaidzein reductase (DHDR), tetrahydrodaidzein reductase (THDR)], were analyzed. Additionally, in vitro functional verification of the newly identified DDRC gene was conducted. It was found that approximately 40% of human samples contained ( S )-equol, whereas 100% of samples from other species contained ( S )-equol. However, there were significant variations in ( S)- equol content among the different species: rats > pigs > chickens > mice > humans. The distributions of the four genes displayed species-specific patterns. High detection rates across various species were exhibited by DHDR , THDR , and DDRC . In contrast, substantial variations in detection rates among different species and individuals were observed with respect to DZNR . It appears that various types of DZNR may be associated with different concentrations of ( S)- equol, which potentially correspond to the regulatory role during ( S)- equol synthesis. This enhances our understanding of individual variations in ( S )-equol production and their connection with functional genes in vitro . Moreover, the newly identified DDRC exhibits higher potential for ( S)- equol synthesis compared to the known DDRC, providing valuable resources for advancing in vitro ( S)- equol production. IMPORTANCE ( S )-equol (( S )-EQ) plays a crucial role in maintaining human health, along with its known capacity to prevent and treat various diseases, including cardiovascular diseases, metabolic syndromes, osteoporosis, diabetes, brain-related diseases, high blood pressure, hyperlipidemia, obesity, and inflammation. However, factors affecting individual variations in ( S )-EQ production and the underlying regulatory mechanisms remain elusive. This study examines the association between functional genes and ( S )-EQ production, highlighting a potential correlation between the DZNR gene and ( S )-EQ content. Various types of DZNR may be linked to the regulation of ( S )-EQ synthesis. Furthermore, the identification of a new DDRC gene offers promising prospects for enhancing in vitro ( S )-EQ production.

[Equol: a Metabolite of Soy Isoflavones by Intestinal Microflora--a Review].

Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects

Metabolism of Dietary Soy Isoflavones to Equol by Human Intestinal Microflora – Implications for Health

Advances in Research on Equol:A Final Metabolite of the Soy Isoflavone

Advances in the Metabolic Mechanism and Functional Characteristics of Equol

[Research Development on Relation Between Equol and Soy Foods Health Effect].

Equol: a metabolite of gut microbiota with potential antitumor effects

Individual Difference in Faecal and Urine Equol Excretion and Their Correlation with Intestinal Microbiota in Large White Sows

Daidzein Intake Is Associated with Equol Producing Status through an Increase in the Intestinal Bacteria Responsible for Equol Production

Comparison of blood and urine concentrations of equol by LC‒MS/MS method and factors associated with equol production in 466 Japanese men and women

Does equol production determine soy endocrine effects?

Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial

Effect of Fermented Soy Beverage on Equol Production by Fecal Microbiota

Compositional and Functional Differences in Human Gut Microbiome with Respect to Equol Production and Its Association with Blood Lipid Level: a Cross-Sectional Study

Lactulose promotes equol production and changes the microbial community during in vitro fermentation of daidzein by fecal inocula of sows

[Microbial Conversion of Daidzein Affects Fecal Equol Concentration and Bacterial Composition of Rats with or Without Ovariectomy].

Quantitative assessment of urinary equol levels, equol-producing bacteria, and the faecal microbiota in healthy Japanese individuals

Prevalence of the Equol-Producer Phenotype and Its Relationship with Dietary Isoflavone and Serum Lipids in Healthy Chinese Adults

Exploring functional genes’ correlation with ( S )-equol concentration and new daidzein racemase identification

[Prevalence of Equol Producer Phenotype and Its Relations to Lifestyle Factors and Dietary Intakes among Lifestyle Factors and Dietary Intakes among Healthy Chinese Adults in Beijing].

To Construct an Engineered (S)-Equol Resistant E. Coli for in Vitro (S)-Equol Production